Aclarion, Inc. (ACON) Research

Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.

Market snapshot

Symbol
ACON
Price
$3.12
Day change
+0.32%
Market cap
$1.7M
P/E ratio
-0.83x
52-week range
2.34-12.03
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 2 months

Peer companies

  • Bullfrog AI Holdings, Inc. Common Stock (BFRG)
  • BNB Plus Corp. (BNBX)
  • Can-Fite BioPharma Ltd. (CANF)
  • Clearmind Medicine Inc. (CMND)
  • Ensysce Biosciences, Inc. (ENSC)
  • Kazia Therapeutics Limited (KZIA)
  • MSP Recovery, Inc. (MSPR)
  • Silo Pharma, Inc. (SILO)

Recent insider activity

  • Bond Ryan — A-Award (55000 shares) on 2026-06-11
  • Sequira Amanda Mae — A-Award (20000 shares) on 2026-06-11
  • Breidbart Scott — A-Award (20000 shares) on 2026-06-11
  • Gould Gregory A — A-Award (50000 shares) on 2026-06-11
  • Ness Brent — A-Award (100000 shares) on 2026-06-11

Open Aclarion, Inc. (ACON) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.